嘉应制药
(002198)
| 流通市值：29.64亿 | | | 总市值：29.64亿 |
| 流通股本：5.07亿 | | | 总股本：5.08亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 148,245,347.24 | 164,645,144.61 | 127,892,923.27 | 201,259,933.75 |
| 交易性金融资产 | 4,095,360 | 12,465,100 | 12,294 | 4,793,858 |
| 应收票据及应收账款 | 236,637,346.94 | 155,854,759.05 | 140,874,326.42 | 152,178,953.16 |
| 其中：应收票据 | 37,519,910.3 | 19,131,895.07 | 5,177,534.75 | 15,167,699.94 |
| 应收账款 | 199,117,436.64 | 136,722,863.98 | 135,696,791.67 | 137,011,253.22 |
| 应收款项融资 | 20,368,782.93 | 18,503,116.03 | 10,062,000.44 | 5,386,262.85 |
| 预付款项 | 68,282,070.52 | 71,597,488.91 | 78,816,564.06 | 8,501,725.31 |
| 其他应收款合计 | 6,593,605.19 | 5,570,341.05 | 22,809,716.16 | 23,125,463.97 |
| 存货 | 57,410,360.94 | 74,039,472.87 | 85,390,635.05 | 83,077,412.75 |
| 其他流动资产 | - | - | 249,780.94 | 222,586.9 |
| 流动资产合计 | 541,632,873.76 | 502,675,422.52 | 466,108,240.34 | 478,546,196.69 |
| 非流动资产: | | | | |
| 长期股权投资 | 41,188,072.26 | 40,975,379.4 | 41,366,643.25 | 42,246,684.98 |
| 固定资产 | 190,852,540.43 | 192,625,731.67 | 170,079,391.32 | 173,907,874.01 |
| 在建工程 | 21,138,868.99 | 16,749,972 | 35,068,391.6 | 32,803,701.85 |
| 无形资产 | 47,596,230.05 | 45,906,134.45 | 46,696,449.97 | 47,125,549.11 |
| 开发支出 | 31,049,056.61 | 30,199,056.61 | 8,927,358.49 | 8,927,358.49 |
| 长期待摊费用 | 6,100,359.58 | 6,880,732.83 | 1,836,939.22 | 2,521,272.07 |
| 递延所得税资产 | 3,811,326.44 | 3,811,326.44 | 4,642,986.26 | 4,642,986.26 |
| 其他非流动资产 | 9,409,755 | 9,409,755 | - | - |
| 非流动资产合计 | 351,146,209.36 | 346,558,088.4 | 308,618,160.11 | 312,175,426.77 |
| 资产总计 | 892,779,083.12 | 849,233,510.92 | 774,726,400.45 | 790,721,623.46 |
| 流动负债: | | | | |
| 短期借款 | 20,000,000 | 0 | - | - |
| 应付票据及应付账款 | 30,471,404.78 | 26,859,966.85 | 9,714,818.31 | 11,827,778.13 |
| 应付账款 | 30,471,404.78 | 26,859,966.85 | 9,714,818.31 | 11,827,778.13 |
| 合同负债 | 2,967,421.19 | 3,493,038.31 | 2,735,503.97 | 2,778,145.49 |
| 应付职工薪酬 | 2,025,924.77 | 5,302,268.42 | 4,363,864.09 | 4,910,106.65 |
| 应交税费 | 9,105,300.97 | 11,593,435.39 | 6,496,551.52 | 4,651,834.6 |
| 其他应付款合计 | 41,125,938.44 | 46,293,424.05 | 6,204,470.05 | 6,028,893.78 |
| 其他流动负债 | 21,788,245.51 | 2,842,329.54 | 1,248,906.79 | 9,608,667.71 |
| 流动负债合计 | 127,484,235.66 | 96,384,462.56 | 30,764,114.73 | 39,805,426.36 |
| 非流动负债: | | | | |
| 递延收益 | 157,505.14 | 172,682.65 | 207,154.73 | 230,268.29 |
| 递延所得税负债 | 34,746,735.76 | 34,746,735.76 | 34,746,735.76 | 34,746,735.76 |
| 非流动负债合计 | 34,904,240.9 | 34,919,418.41 | 34,953,890.49 | 34,977,004.05 |
| 负债合计 | 162,388,476.56 | 131,303,880.97 | 65,718,005.22 | 74,782,430.41 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 507,509,848 | 507,509,848 | 507,509,848 | 507,509,848 |
| 资本公积 | 109,320,129.52 | 124,360,206.41 | 123,652,931.39 | 123,652,931.39 |
| 减:库存股 | 54,158,428.4 | 69,995,228.4 | 69,995,657.57 | 61,301,621.53 |
| 其他综合收益 | -2,480,299.31 | -1,480,604.83 | -1,011,000 | -1,062,500 |
| 盈余公积 | 28,034,245.77 | 28,034,245.77 | 27,767,450.89 | 27,767,450.89 |
| 未分配利润 | 142,165,110.98 | 129,501,163 | 121,084,822.52 | 119,373,084.3 |
| 归属于母公司股东权益合计 | 730,390,606.56 | 717,929,629.95 | 709,008,395.23 | 715,939,193.05 |
| 股东权益合计 | 730,390,606.56 | 717,929,629.95 | 709,008,395.23 | 715,939,193.05 |
| 负债和股东权益合计 | 892,779,083.12 | 849,233,510.92 | 774,726,400.45 | 790,721,623.46 |
| 公告日期 | 2026-04-30 | 2026-04-30 | 2025-10-29 | 2025-08-26 |
| 审计意见(境内) | | 保留意见 | | |